Securities Fraud Suit Follows Pfizer's Drug Collapse
A class action law firm has filed a securities fraud lawsuit against Pfizer Inc., just days after the drug giant scrapped its highly anticipated cholesterol drug torcetrapib, which took 15 years...To view the full article, register now.
Already a subscriber? Click here to view full article